The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma

被引:0
|
作者
Cunzhen Shi
Xiangqun Li
Xiaogan Wang
Ning Ding
Lingyan Ping
Yunfei Shi
Lan Mi
Yumei Lai
Yuqin Song
Jun Zhu
机构
[1] Peking University Cancer Hospital & Institute,Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma
[2] Beijing Doing Biomedical Technology Co.,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology
[3] Ltd,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)
[4] Peking University Cancer Hospital & Institute,undefined
[5] Peking University Cancer Hospital & Institute,undefined
关键词
Mer tyrosine kinase; Mantle cell lymphoma; Therapeutic target; UNC2250;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] THE PRODUCT OF THE C-FMS PROTO-ONCOGENE - A GLYCOPROTEIN WITH ASSOCIATED TYROSINE KINASE-ACTIVITY
    RETTENMIER, CW
    CHEN, JH
    ROUSSEL, MF
    SHERR, CJ
    SCIENCE, 1985, 228 (4697) : 320 - 322
  • [32] CLONING AND EXPRESSION OF THE RET PROTO-ONCOGENE ENCODING A TYROSINE KINASE WITH 2 POTENTIAL TRANSMEMBRANE DOMAINS
    TAKAHASHI, M
    BUMA, Y
    IWAMOTO, T
    INAGUMA, Y
    IKEDA, H
    HIAI, H
    ONCOGENE, 1988, 3 (05) : 571 - 578
  • [33] Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma
    Maegawa, Saori
    Chinen, Yoshiaki
    Shimura, Yuji
    Tanba, Kazuna
    Takimoto, Tomoko
    Mizuno, Yoshimi
    Matsumura-Kimoto, Yayoi
    Kuwahara-Ota, Saeko
    Tsukamoto, Taku
    Kobayashi, Tsutomu
    Horiike, Shigeo
    Taniwaki, Masafumi
    Kuroda, Junya
    EXPERIMENTAL HEMATOLOGY, 2018, 59 : 72 - 81
  • [34] MER TYROSINE KINASE POSITIVE TUMOUR ASSOCIATED MACROPHAGES ARE A NOVEL THERAPEUTIC TARGET IN HEPATOCELLULAR CARCINOMA
    Mukherjee, S. K.
    Pop, O. T.
    Triantafyllou, E.
    Khamri, W.
    Bernsmeier, C.
    Li, K. -K.
    Suddle, A.
    Weston, C.
    Curbishley, S.
    Thursz, M.
    Adams, D.
    Heaton, N.
    Quaglia, A.
    Antoniades, C. G.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S574 - S575
  • [35] Rac1 is a novel therapeutic target in mantle cell lymphoma
    Tian, Tian
    Bi, Chengfeng
    Hein, Ashley L.
    Zhang, Xuan
    Wang, Cheng
    Shen, Songfei
    Yuan, Ji
    Greiner, Timothy C.
    Enke, Charles
    Vose, Julie
    Yan, Ying
    Fu, Kai
    BLOOD CANCER JOURNAL, 2018, 8
  • [36] Rac1 is a novel therapeutic target in mantle cell lymphoma
    Tian Tian
    Chengfeng Bi
    Ashley L. Hein
    Xuan Zhang
    Cheng Wang
    Songfei Shen
    Ji Yuan
    Timothy C. Greiner
    Charles Enke
    Julie Vose
    Ying Yan
    Kai Fu
    Blood Cancer Journal, 8
  • [37] The proto-oncogene p120Cbl is a downstream substrate of the Hck protein-tyrosine kinase
    Howlett, CJ
    Bisson, SA
    Resek, ME
    Tigley, AW
    Robbins, SM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) : 129 - 138
  • [38] The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A
    Stachelscheid, Johanna
    Jiang, Qu
    Herling, Marco
    CANCERS, 2021, 13 (21)
  • [39] Activity of Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Mantle Cell Lymphoma (MCL) Identifies Btk As a Novel Therapeutic Target
    Ponader, Sabine
    Balasubramanian, Sriram
    Pham, Lan V.
    Chen, Jun
    Tamayo, Archito T.
    Wang, Michael
    O'Brien, Susan
    Wierda, William G.
    Keating, Michael J.
    Ford, Richard J.
    Burger, Jan A.
    BLOOD, 2011, 118 (21) : 1576 - 1576
  • [40] A CHIMERIC EGF-R-NEU PROTO-ONCOGENE ALLOWS EGF TO REGULATE NEU TYROSINE KINASE AND CELL-TRANSFORMATION
    LEHVASLAIHO, H
    LEHTOLA, L
    SISTONEN, L
    ALITALO, K
    EMBO JOURNAL, 1989, 8 (01): : 159 - 166